Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

PuraMed BioScience, Inc. (PMBS)

PMBS RSS Feed
Add PMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, Tadaaa, rs99, stockchaser64, MoneyStocksID2014, Meach2
Search This Board:
Last Post: 9/17/2014 8:47:57 PM - Followers: 337 - Board type: Free - Posts Today: 27





OTCPINK
PuraMed BioScience, Inc. is a U.S. SEC Registered & Reporting Company
http://www.otcmarkets.com/stock/pmbs/quote

Symbol: PMBS

https://www.puramedbioscience.com/

http://www.lipigesic.com/



Share Structure:
 As Of July 24th, 2014  1.4 Billion Shares as Float (O/S)

As Of July 24th, 2014  4 Billion Shares Authorized (A/S)

40/1 Reverse Split in the Process which per company filings will result in Approximately 37 Million Shares Outstanding and Meet the OTCQB requirements.





 

About the Company

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic® M (for acute relief of migraine headaches), LipiGesic® H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience has completed a double blind placebo clinical trial for its leading product, LipiGesic® M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract 
LipiGesic® M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.


CLICK HERE to Read Lipigesic Clinical Trial 2011 Study

 

Products

Feverfew 3X, the main active ingredient in LipiGesic® M (for migraine relief), is an herb that has been recognized for centuries as having a beneficial effect on migraine, menstrual and other headaches. Another active ingredient, Ginger 2X, is anti-inflammatory, specifically suppressing the expression of several mediators felt crucial in migraine pathogenesis.
Read more: http://www.puramedbioscience.com/lipigesic-m/


 

A combination of acetylsalicylic acid (aspirin) and St. John’s Wort delivered utilizing our sublingual gel delivery system can dramatically increase the speed and levels of relief for many tension headache sufferers.
Read more: http://www.puramedbioscience.com/lipigesic-h/

 


 

Valerian, St. John’s Wort and Chamomile, all ingredients in LipiGesic® PM (for insomnia), have each been clinically demonstrated to promote healthy sleep. 
Read more: http://www.puramedbioscience.com/lipigesic-pm/

 




Where to Buy

LipiGesic M is will be available in CVS and Walgreens pharmacy stores!

New Distributors to be Announced soon!!!

 

 
 

Click Here to Buy Online:

 
 
http://www.calciumsupreme.com/lipigesic

PMBS product are also in stock and available thru the following retailers as of 07/30/2014-also this is not a complete list:
Healthy Grade Supplements 
AeroComp 
Ezpickin 
Itzadeal 
C&KShoppe 
Dynamic Marketing Concepts USA 
Amaday in Paradise 
December Sun Market 
C-C Warehouse


Recent News

   

PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

 

SCHOFIELD, Wis., Aug. 5, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.

"As we looked at the similarities between migraine and epilepsy the treatment path became obvious," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "Epilepsy and migraine seem to be triggered by the same coritcal spreading depression (CSD) in the brain; the difference is the rate of reaction. This may be why many migraineurs are prescribed epileptic medications."

According to an article in Seizure, the prevalence of migraine in people who experience epilepsy is 8.4 to 20 percent. In addition to migraine, an estimated 64 percent of epilepsy sufferers also experience seizure-related (ictal) headaches: 20 percent experience headache prior to the seizure (pre-ictal) and 44 percent experience headache after the seizure (post-ictal).

The third most common neurological disorder in the US, epilepsy affects approximately 2.7 million people, with children and older adults being most susceptible. The condition also causes up to 50,000 sudden deaths each year.

Epilepsy affects veterans wounded in combat. According to Citizens United to Cure Epilepsy, approximately 22 percent of the 440,000 military service men and women who experienced traumatic brain injury are expected to develop post-traumatic epilepsy.

"An epilepsy medication is a natural extension to our product line," said Mitchell. "We have developed a formula, now we will begin the setting up the trials. We have been approached by key researchers who have expressed interest in working with us on CBD-based products.

"Standardization is key to creating a quality sublingual formula," said Mitchell. " Sublingual delivery offers the distinct advantages of faster delivery and efficiency while avoiding the "first pass effect" that often degrades oral medications. Our goal is to build medicines that withstand scientific scrutiny and perform well in double-blind, placebo controlled clinical trials. We believe that the efficacy of our formulations will be proven by scientific trials. This type of testing lends credibility to our line of natural medications which often work faster, more effectively, and have fewer side effects than their chemical-based counterparts."

Currently, PuraMed BioScience is rebranding its flagship product, LipiGesic M, as MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this homeopathic, all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, is the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact: 
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO 
715-359-6373
rmitchell@PuramedBioScience.com 
www.PuramedBioScience.com

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M

 

SCHOFIELD, Wis., July 30, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure®  going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.

"We've been working on this for over a year," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "We needed to secure the trademark for the name and create the image before we announced the development of the enhanced formula and our product line extensions. 

"The new name will be easier for people to remember and pronounce," said Mitchell. "We also believe the new look and color of the logo will convey our 'safe' and 'natural' message at a glance. Preliminary feedback about the change has been positive and we are pleased. We will now have packaging that reflects the excellent product inside."

PuraMed hopes to have the new product, which uses a flavor-enhanced version of the sublingual LipiGesic M formula, new packaging, new price point, and a new website ready for public purchase within the next two months, though promotion and distribution to retailers and targeted wholesale partners will begin earlier.

"The manufacturing order has been placed," said Mitchell. "Our marketing plan is being finalized and as soon as the packaging and the website are ready, we will launch."

MigraPure's fresh look and message will replace the red and yellow LipiGesic logo. A tagline that describes the product will also be a fundamental part of the logo.

"By using a tagline with the image, we can make a stronger statement and leave no doubt in the consumer's mind about what MigraPure is or what it does, which is also an improvement," said Mitchell. "During the re-launch, we will also reference LipiGesic M on the packaging and other marketing materials in order to maintain a connection with our clinical trial data and our current customer base."

Development of the gel, packaging, and launch of the website are the first steps in the rebranding effort. PuraMed plans to continue to sell LipiGesic M under the old label until the new product is available.

A version of the new logo can be seen at www.lipigesic.com/MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, are the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

SOURCE PuraMed BioScience, Inc.

Current LipiGesic M videos

  Dr. Cady videoDr. Roger Cady, discusses the results of treatment of migraine headache with fever few and ginger, the active ingredients in the migraine treatment LipiGesic® M.
VIEW NOW
  Sherry TorkosPharmacist Sherry Torkos recommends all-natural, homeopathic LipiGesic® M.
VIEW NOW
  Nutrition and J.J. Virgin fitness expert J.J. Virgin shares how LipiGesic® M has helped her teenage son eliminate migraine pain.
VIEW NOW

 

 


 

 



      REBRANDING, TRADEMEARK AND PATENTS ARE NOW COMPLETE 07/30/2014      


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
PMBS News: PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 07/22/2014 08:49:00 AM
PMBS News: PuraMed BioScience Announces Product Donation at a Sponsorship Level to Operation Gratitude 07/08/2014 09:11:00 AM
PMBS News: PuraMed BioScience and Honoring Our Troops Partner Together to Sponsor a PTSD Event 06/11/2014 08:00:00 AM
PMBS News: PuraMed BioScience moves forward with the development of its first cannabinoid-based medicine 04/09/2014 07:25:00 PM
PostSubject
#17728  Sticky Note ~Key Elements of Recent Filings~ MoneyStocksID2014 07/30/14 08:41:31 AM
#16148  Sticky Note 07-11-14/ Report Filing (8-k) Puramed Bioscience, Inc. (PC) mick 07/11/14 09:01:50 PM
#10811  Sticky Note THIS PR IS GETTING NATION WIDE COVERAGE!..THIS IS vans 04/10/14 01:32:15 AM
#19645   A Very Sober Post: RS99, it is curious Future8Jerry 09/17/14 09:36:18 PM
#19644   I believe that the IQ of several posters wodehouse 09/17/14 08:47:57 PM
#19643   22 Mil Volume WOW !! inplay 09/17/14 08:08:59 PM
#19642   I couldn't have put it better myself. There XYREUS 09/17/14 07:08:52 PM
#19641   Well buy buy buy then. How many are rs99 09/17/14 06:49:04 PM
#19640   Believe me i understand your concerns. I definitely rs99 09/17/14 06:44:15 PM
#19639   You're proof that PMBS is testing their Mongol76 09/17/14 06:14:22 PM
#19638   22 million volume it's time to Buy ! inplay 09/17/14 04:36:14 PM
#19637   The question still remains. Whether u buy now XYREUS 09/17/14 03:10:44 PM
#19636   You can buy a billion shares if you rs99 09/17/14 12:50:29 PM
#19635   Who knows. They were supposed to file in rs99 09/17/14 12:41:07 PM
#19634   No, sorry, but we don't "buy it" anymore. XYREUS 09/17/14 12:31:03 PM
#19633   PMBS $$$$ Buy! Buy! Buy! inplay 09/17/14 12:19:59 PM
#19632   What day does the blood bath start? Lockman 09/17/14 11:44:39 AM
#19631   Hey, you admitted that you know nothing about rs99 09/17/14 10:42:32 AM
#19630   Do you want to say it again? wodehouse 09/17/14 10:23:51 AM
#19628   PMBS soon to pennyland and beyond!! $$$$$ I brando5 09/17/14 10:13:56 AM
#19627   And his name was Marlon. wodehouse 09/17/14 10:08:54 AM
#19626   There's only one Brando... brando5 09/17/14 10:00:27 AM
#19625   That's understandable. Then wait and watch. brando5 09/17/14 09:58:38 AM
#19624   Its called there's long-term investors who are brando5 09/17/14 09:57:29 AM
#19623   Day 20-and-still NO filing in Nevada! Go-Russ rs99 09/17/14 09:23:53 AM
#19621   Do you have an explanation how Brandos exist XYREUS 09/17/14 12:40:07 AM
#19620   I agree, an r/s with continued dilution should Mongol76 09/17/14 12:24:04 AM
#19619   I'm sorry, I stand corrected. I threw up XYREUS 09/17/14 12:11:21 AM
#19618   I think this is the second time you Mongol76 09/16/14 11:54:04 PM
#19617   Hey, now is SOOOO exciting! Anyday now we XYREUS 09/16/14 11:11:14 PM
#19616   No, you are going on hopes and dreams. rs99 09/16/14 10:48:01 PM
#19615   When u have lunch with us, let him XYREUS 09/16/14 06:32:27 PM
#19614   I mistyped the one post. But it did brando5 09/16/14 06:19:30 PM
#19613   "You don't know for sure anything"... you don't XYREUS 09/16/14 06:10:30 PM
#19612   That's why things are so exciting now, things brando5 09/16/14 06:00:56 PM
#19611   You don't communicate that correct. There will be brando5 09/16/14 05:53:44 PM
#19610   They have meeting all the time at the brando5 09/16/14 05:50:06 PM
#19609   Wow!!!! Hiw did you find out about the XYREUS 09/16/14 04:59:28 PM
#19608   Reverse Split, is probably what will happen. nomorebanksters 09/16/14 03:22:58 PM
#19607   I am more than fully aware of dilution rs99 09/16/14 03:14:13 PM
#19606   Also, there will be some important meetings I brando5 09/16/14 03:01:23 PM
#19605   In case you are unaware, ALL publically traded brando5 09/16/14 02:56:50 PM
#19604   He has stated his interest in doing so brando5 09/16/14 02:53:42 PM
#19603   Two and a half week computer glitch!!..lol..Go-Russ-Mitchell!!! rs99 09/16/14 01:56:16 PM
#19602   It's the same thing really. What Russ Mongol76 09/16/14 01:47:14 PM
#19601   Is this in your opinion or has Russ rs99 09/16/14 01:06:59 PM
#19600   Again, it takes money which this company has rs99 09/16/14 01:04:44 PM
#19599   There will more than likely be an authorized brando5 09/16/14 01:00:55 PM
#19598   Advertisement and marketing will be done more than brando5 09/16/14 01:00:00 PM
#19597   The point is at .0001, with a company XYREUS 09/16/14 12:59:08 PM
#19596   Takes huge amounts of money. This company is broke! rs99 09/16/14 12:57:13 PM
#19595   There were. problems with its marketing last time. brando5 09/16/14 12:55:48 PM
#19594   Well, I'm still holding my shares, but do wodehouse 09/16/14 12:22:33 PM
PostSubject